Applied DNA Sciences (APDN)

Applied DNA Sciences (APDN) Financial Statements


Applied DNA Sciences Financial Overview

Applied DNA Sciences's market cap is currently ―. The company's EPS TTM is $-0.543; its P/E ratio is -1.65; Applied DNA Sciences is scheduled to report earnings on December 21, 2023, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 2.92M-$ 5.26M$ 3.56M$ 4.30M
Gross Profit$ 2.92M$ -2.60M$ 2.38M$ 416.76K$ 1.04M
EBIT$ -3.14M$ 551.18K$ -3.85M$ -4.37M$ -2.84M
EBITDA$ -2.79M$ 895.68K$ -3.51M$ -4.04M$ -2.52M
Net Income Common Stockholders$ -3.10M$ 588.34K$ -3.84M$ -663.22K$ -1.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.76M$ 12.29M$ 12.88M$ 15.22M$ 4.68M
Total Assets$ 15.79M$ 19.18M$ 20.30M$ 22.27M$ 11.92M
Total Debt$ 1.36M$ 1.47M$ 0.00$ 0.00$ 0.00
Net Debt$ -9.40M$ -10.82M$ -12.88M$ -15.22M$ -4.68M
Total Liabilities$ 8.60M$ 9.21M$ 11.14M$ 9.36M$ 5.13M
Stockholders Equity$ 7.25M$ 10.01M$ 9.16M$ 12.91M$ 6.80M
Cash Flow-
Free Cash Flow$ -1.39M$ 160.05K$ -2.34M$ -3.50M$ -1.83M
Operating Cash Flow$ -1.37M$ 214.39K$ -2.38M$ -3.26M$ -1.75M
Investing Cash Flow$ -161.80K$ -54.34K$ 45.00K$ -242.66K$ -76.67K
Financing Cash Flow---$ 14.03M$ 75.00
Currency in USD

Applied DNA Sciences Earnings and Revenue History

Applied DNA Sciences Debt to Assets

Applied DNA Sciences Cash Flow

Applied DNA Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis